Streetbeat News

Partnerships

CARM

Carisma Therapeutics Inc. (NASDAQ:CARM) shares surged on Friday following a significant development in its collaboration with Moderna. Carisma nominated its first in vivo CAR-M development candidate targeting Glypican-3 (GPC3) for treating solid tumors, triggering a $2 million payment from Moderna. HC Wainwright & Co. reiterated a Buy rating with a price target of $8.

Portfolio Pulse from Vaishali Prayag

June 28, 2024 | 5:59 pm

RIVN

VLKAF

Needham analyst Chris Pierce reiterated a Buy rating on Rivian Automotive, Inc. (NASDAQ:RIVN), raising the price forecast to $20 from $13. Pierce sees Rivian as a long-term winner in the EV transition, highlighting its strategic focus on cost savings, supplier relationships, and factory efficiencies. The recent Volkswagen JV is expected to provide up to $5 billion in capital, boosting Rivian's software-defined vehicle strategy. Pierce also raised the FY24 revenue forecast to $4.563 billion from $4.254 billion. Despite these positive outlooks, RIVN shares are trading lower by 7% to $13.46.

Portfolio Pulse from Nabaparna Bhattacharya

June 28, 2024 | 5:23 pm

LUCY

Innovative Eyewear, Inc. (NASDAQ:LUCY) shares are surging on heavy trading volume following a recent sales and marketing update. The company announced a new partnership with Windsor Eyes and the launch of its Amazon store in Germany. LUCY shares are up 65.2% at 54 cents.

Portfolio Pulse from Erica Kollmann

June 28, 2024 | 5:01 pm

BYDDF

BYDDY

TM

BYD Co., Ltd. (OTC:BYDDY) (OTC:BYDDF) has commenced production of its first hybrid SUVs at its Uzbekistan plant, marking a significant milestone. The company aims to drive green transportation in the region and has plans to expand its NEV industry in Central Asia. Additionally, BYD has started selling a third electric model in Japan.

Portfolio Pulse from Nabaparna Bhattacharya

June 28, 2024 | 4:53 pm

RIVN

Rivian Automotive (NASDAQ:RIVN) shares are trading lower on Friday after earlier gains due to a partnership with Volkswagen and the company's investor day. Rivian expects Q2 vehicle production between 9,100 and 9,300 units and aims to produce 57,000 vehicles in 2024. The R2 model EV is set to launch in the first half of 2026. Analysts have updated their coverage, with mixed ratings and price targets ranging from $10 to $23.

Portfolio Pulse from Erica Kollmann

June 28, 2024 | 4:51 pm

ESPR

Esperion Therapeutics shares are trading lower after the company announced a Royalty Purchase Agreement with OMERS Life Sciences. The stock initially traded higher but has since reversed.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 4:15 pm

EWJ

EWY

SPY

Donald Trump's allies are assuring officials in Japan and South Korea that Trump will support efforts to deepen ties between the three nations if he takes office again. This includes military, economic, and diplomatic cooperation to counter China and North Korea. The outreach is part of a broader effort to sketch policy priorities for a potential second Trump presidency.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:46 pm

BTCUSD

The Core Foundation is launching the world's first yield-bearing CORE ETP on the Spotlight Stock Exchange, facilitated by Valour, a subsidiary of DeFi Technologies. This ETP will provide exposure to Core blockchain's native token and follows the successful release of Valour's Bitcoin Staking ETP.

Portfolio Pulse from Murtuza Merchant

June 28, 2024 | 3:28 pm

BTCUSD

ETHUSD

Kraken Co-Founder Jesse Powell has endorsed Donald Trump, the 'only pro-crypto major party candidate,' and donated $1 million in Ethereum to his campaign. Trump has shown support for the crypto sector but has yet to propose specific policies.

Portfolio Pulse from Murtuza Merchant

June 28, 2024 | 3:24 pm

LUCY

Innovating Eyewear shares are trading higher after the company announced progress in international expansion.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:16 pm